A carregar...
Visceral Leishmaniasis – Optimum Treatment Options in Children
Visceral leishmaniasis (VL) affects 200-400 thousands people annually worldwide. For last few decades there has been a steady decline in the response to pentavalent antimonial (Sb(v)), the drug that has been used for treating VL for almost a century. Oral miltefosine and amphotericin B are alternati...
Na minha lista:
| Publicado no: | Pediatr Infect Dis J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990428/ https://ncbi.nlm.nih.gov/pubmed/29280784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001885 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|